A Multi-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorJie Liang

About this trial

This multi-center, prospective, randomized controlled trial evaluates whether disease subtype-based active video education improves bowel preparation quality in patients with inflammatory bowel disease (IBD) undergoing colonoscopy. A total of 600 IBD patients from 13 centers will be randomized 1:1 to standard education plus subtype-specific video education (intervention group) or standard education alone (control group). The primary outcome is the Boston Bowel Preparation Scale (BBPS) score.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 18 and 75 years, inclusive.

Confirmed diagnosis of Ulcerative Colitis (UC) or Crohn's disease (CD) according to standard clinical guidelines.

Scheduled for elective colonoscopy for IBD monitoring or disease activity assessment.

Able to understand written and verbal instructions and to use a smartphone to view video education materials.

Disqualifiers

Absolute contraindications to colonoscopy, including acute gastrointestinal perforation, fulminant colitis, toxic megacolon, or hemodynamic instability.

History of total or subtotal colectomy.

Acute or chronic intestinal obstruction.

Severe cardiac, pulmonary, hepatic, or renal insufficiency (eGFR <30 mL/min/1.73m², NYHA class III/IV).

Trial design

Design model

Parallel

Treatments tested in this trial

  • Disease Subtype-Based Active Video Education

    Behavioral

    A structured, subtype-specific educational video program tailored for patients with inflammatory bowel disease (IBD). The videos are customized based on IBD subtype (ulcerative colitis/Crohn's disease), disease activity (active/remission), and Crohn's disease behavior (stricturing/fistulizing). It covers key topics including dietary restrictions, laxative intake instructions, symptom management, and practical problem-solving strategies to improve understanding and adherence to bowel preparation protocols. The video is delivered via WeChat link.

  • standard bowel preparation education

    Behavioral

    standard bowel preparation education

Treatment groups

600 Participants
are divided into 2 treatment groups
Group A: Intervention Group (Active Video Education Group)Experimental treatment 2 interventions
Group B: Control Group (Conventional Education Group)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Bowel Preparation Quality (Boston Bowel Preparation Scale, BBPS)

The Boston Bowel Preparation Scale (BBPS) is a validated scoring system to assess the cleanliness of three colonic segments: right colon (including cecum and ascending colon), transverse colon (including hepatic flexure and splenic flexure), and left colon (including descending colon, sigmoid colon, and rectum). Each segment is scored from 0 (unprepared) to 3 (excellent) by the endoscopist during withdrawal. The total BBPS score ranges from 0 to 9. Higher scores indicate better bowel preparation.

Time frame
Periprocedural (during colonoscopy)

Secondary outcomes

1

Adequate Bowel Preparation Rate

Proportion of patients with adequate bowel preparation, defined as total BBPS score ≥ 6.

Time frame
Periprocedural (during colonoscopy)
2

Excellent Bowel Preparation Rate

Proportion of patients with excellent bowel preparation, defined as total BBPS score ≥ 8.

Time frame
Periprocedural (during colonoscopy)
3

Cecal Intubation Rate

Proportion of patients in whom the cecum is successfully intubated during colonoscopy.

Time frame
Periprocedural (during colonoscopy)
4

Cecal Intubation Time

Time (in seconds) required to reach and intubate the cecum, measured from the time the colonoscope is inserted until cecal intubation is confirmed.

Time frame
Periprocedural (during colonoscopy)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jie Liang

Lead sponsor

Xijing Hospital of Digestive Diseases

Sponsor institution

Xijing Hospital of Digestive Diseases

Collaborator

Peking Union Medical College Hospital

Collaborator

Shengjing Hospital

Collaborator

RenJi Hospital

Collaborator

Changhai Hospital

Collaborator

First Affiliated Hospital of Xinjiang Medical University

Collaborator

Affiliated Hospital of Qinghai University

Collaborator

Second Affiliated Hospital of Xi'an Jiaotong University

Collaborator

Air Force 986 Hospital

Collaborator

Shanxi Yuncheng Central Hospital

Collaborator

Ruijin Hospital

Collaborator

Changzhi Medical College

Collaborator

Linfen Central Hospital

Collaborator